The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Genetics affects functions of gut microbiome
Pharma & Human Health

Genetics affects functions of gut microbiome

APR 28, 2022
Protecting the human intestinal microbiome with synthetic biology
Gastrointestinal

Protecting the human intestinal microbiome with synthetic biology

APR 18, 2022
Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers
Editor's Choice

Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers

APR 15, 2022
Did you miss Probiota Copenhagen 2022? Catch up now!
Editor's Choice

Did you miss Probiota Copenhagen 2022? Catch up now!

APR 12, 2022
Microba Life Sciences Completes Successful IPO & Announces Partnership with Ginkgo Bioworks
Finance

Microba Life Sciences Completes Successful IPO & Announces Partnership with Ginkgo Bioworks

APR 4, 2022
Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund
Finance

Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund

APR 4, 2022
Researchers identify potential approaches to modify the vaginal microbiome
Pharma & Human Health

Researchers identify potential approaches to modify the vaginal microbiome

MAR 30, 2022
How insights from the field of advanced therapy medicinal products (ATMPs) can inform solutions in the microbiome field
Finance

How insights from the field of advanced therapy medicinal products (ATMPs) can inform solutions in the microbiome field

MAR 23, 2022
A new photoactive viral vector for anti-cancer therapy has been developed
GMO & Synbio

A new photoactive viral vector for anti-cancer therapy has been developed

MAR 15, 2022
Pherecydes Pharma and BIOASTER Join Forces in the Treatment of Bacteremia
Finance

Pherecydes Pharma and BIOASTER Join Forces in the Treatment of Bacteremia

MAR 14, 2022
Deciphering gut microbiome ‘chatter’ to combat IBD
Gastrointestinal

Deciphering gut microbiome ‘chatter’ to combat IBD

MAR 14, 2022